Literature DB >> 30025721

Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes.

Piotr Alster1, Ewa Krzyżanowska2, Dariusz Koziorowski3, Stanisław Szlufik3, Dorota Różański3, Joanna Noskowska2, Justyna Mianowicz2, Adrian Michno2, Leszek Królicki4, Andrzej Friedman3.   

Abstract

Corticobasal Degeneration Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) are types of four repeats (4R) tauopathies, which are associated to parkinsonian syndromes. The aim of the work is to analyze cases of patients of the Department of Neurology, overlapping of syndromes related to both pathologies and to show that most likely CBS and PSP are not lineary related to their commonly associated syndromes i.e. adequately corticobasal syndromes and progressive supranuclear palsy syndromes. In the context of each patient factors in favor of most likely CBS, PSP or both diseases are discussed and analyzed using contemporary criteria. This work discusses multidimensional aspect of the examination of five patient aged 64 to 83 - 4 females and 1 male with 4R tauopathies and difficulties in distinguishing both diseases. The duration of the disease varied from 1 to 5 years. Each patient after neurological examination was assessed using magnetic resonance imaging (MRI) and psychological test. Examination of all patients was extended using single photon emission computer tomography (SPECT) to reveal the usefulness of this tool in differentiation of diseases was done. The outcome of this examination was verified with prior clinical manifestation of patients and morphological abnormalities in magnetic resonance imaging. Autopsies were not conducted.
Copyright © 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Atypical parkinsonism; CBD; CBS; PSP; Tauopathy

Mesh:

Year:  2018        PMID: 30025721     DOI: 10.1016/j.pjnns.2018.06.002

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  6 in total

1.  Japanese Familial Cases of Frontotemporal Dementia and Parkinsonism with N279K Tau Gene Mutation.

Authors:  Yuwa Oka; Hidemoto Saiki; Yasumasa Hashimoto; Yuta Terada; Takashi Nakamura; Takashi Ayaki; Satoshi Orimo; Sadayuki Matsumoto
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

Review 2.  Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS).

Authors:  Piotr Alster; Natalia Katarzyna Madetko; Dariusz Mariusz Koziorowski; Leszek Królicki; Sławomir Budrewicz; Andrzej Friedman
Journal:  Front Neurol       Date:  2019-02-14       Impact factor: 4.003

3.  MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.

Authors:  Rebecca R Valentino; Shunsuke Koga; Ronald L Walton; Alexandra I Soto-Beasley; Naomi Kouri; Michael A DeTure; Melissa E Murray; Patrick W Johnson; Ronald C Petersen; Bradley F Boeve; Ryan J Uitti; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross; Michael G Heckman
Journal:  Acta Neuropathol Commun       Date:  2020-12-07       Impact factor: 7.801

4.  The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.

Authors:  Piotr Alster; Natalia Madetko; Bartosz Migda; Michał Nieciecki; Michał Kutyłowski; Leszek Królicki; Andrzej Friedman
Journal:  Diagnostics (Basel)       Date:  2022-07-09

5.  High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer's Disease Patients but Not in Non-Alzheimer's Disease Dementia.

Authors:  Giulia Bivona; Matilda Iemmolo; Tommaso Piccoli; Luisa Agnello; Bruna Lo Sasso; Marcello Ciaccio; Giulio Ghersi
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

Review 6.  Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences.

Authors:  Dariusz Koziorowski; Monika Figura; Łukasz M Milanowski; Stanisław Szlufik; Piotr Alster; Natalia Madetko; Andrzej Friedman
Journal:  Cells       Date:  2021-03-16       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.